Evaluation of multiple sclerosis diagnostic criteria in Suzhou, China - Risk of under-diagnosis in a low prevalence area

Acta Neurologica Scandinavica

Volumn 121, Issue 1, 2010, Pages 24-29

  Cheng, X J ^a   Cheng, Q ^a,f   Xu, L Z ^b   Zhao, H Q ^b   Zhao, Z ^c   Wang, W ^c   Jiang, G X ^a,d   Fredrikson, S ^e  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c Suzhou No 2 People's Hospital   (China)

^d KAROLINSKA INSTITUTE   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

China; Demyelinating disease; Discharge diagnoses; Multiple sclerosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHINA; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE SCLEROSIS; PATIENT IDENTIFICATION; PREVALENCE; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CATCHMENT AREA (HEALTH); CHILD; CHINA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; ENCEPHALITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELITIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 74049124326     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01276.x     Document Type: Article

References (29)

1. Coo H, Aronson KJ. A systematic review of several potential non-genetic risk factors for multiple sclerosis. Neuroepidemiology 2004 23 : 1 12.
2. Ebers GC. A twin consensus in MS. Mult Scler 2005 11 : 497 499.
3. Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 2004 3 : 709 718.
4. Tajouri L, Fernandez F, Griffiths LR. Gene expression studies in multiple sclerosis. Curr Genomics 2007 8 : 181 189.
5. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 13 : 227 231.
6. Seewann A, Kooi E-J, Roosendaal SD, Barkhof F, Van Der Valk P, Geurts JJ. Translating pathology in multiple sclerosis: the combination of postmortem imaging, histopathology and clinical findings. Acta Neurol Scand 2009 119 : 349 355.
7. Bot JC, Barkhof F, Lycklama A et al. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 2002 223 : 46 56.
8. Lycklama G, Thompson A, Filippi M et al. Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2003 2 : 555 562.
9. Miller DH, Filippi M, Fazekas F et al. Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol 2004 56 : 273 278. (Pubitemid 39037922)
10. Poser CM, Brinar VV. Disseminated encephalomyelitis and multiple sclerosis: two different diseases - a critical review. Acta Neurol Scand 2007 116 : 201 206.
11. Mcfarland HF, Barkhof F, Antel J, Miller DH. The role of MRI as a surrogate outcome measure in multiple sclerosis. Mult Scler 2002 8 : 40 51.
12. Mcdonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 50 : 121 127.
13. Polman CH, Reingold SC, Edan G et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol 2005 58 : 840 846.
14. Cohen J. A coefficient of agreement for nominal scale. Educ Psychol Meas 1969 20 : 37 46.
15. Rothwell PM, Charlton D. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1998 64 : 730 735.
16. Wasay M, Khatri IA, Khealani B, Sheerani M. MS in Asian countries. Int MS J 2006 13 : 58 65.
17. Cheng Q, Miao L, Zhang J et al. A population-based survey of multiple sclerosis in Shanghai, China. Neurology 2007 68 : 1495 1500.
18. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002 104 : 182 191.
19. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001 22 : 117 139.
20. Cheng Q, Miao L, Zhang J et al. Clinical features of patients with multiple sclerosis from a survey in Shanghai, China. Mult Scler 2008 14 : 671 678.
21. Houzen H, Niino M, Kikuchi S et al. The prevalence and clinical characteristics of MS in northern Japan. J Neurol Sci 2003 211 : 49 53.
22. Fox CM, Bensa S, Bray I, Zajicek JP. The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria. J Neurol Neurosurg Psychiatry 2004 75 : 56 60.
23. Polman CH, Wolinsky JS, Reingold SC. Multiple sclerosis diagnostic criteria: three years later. Mult Scler 2005 11 : 5 12.
24. Zipoli V, Portaccio E, Siracusa G, Pracucci G, Sorbi S, Amato MP. Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosis. Mult Scler 2003 9 : 481 485.
25. Korteweg T, Tintore M, Uitdehaag B et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol 2006 5 : 221 227.
26. Dalton CM, Brex PA, Miszkiel KA et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002 52 : 47 53.
27. Tintore M, Rovira A, Rio J et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003 60 : 27 30.
28. Kikuchi S, Fukazawa T, Niino M et al. HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen. Neurology 2003 60 : 647 651.
29. Imrell K, Landtblom AM, Hillert J, Masterman T. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 2006 67 : 1062 1064.